Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Getting to 90-90-90 in paediatric HIV: What is needed?

Davies MA, Pinto J, Bras M.

J Int AIDS Soc. 2015 Dec 2;18(7Suppl 6):20770. doi: 10.7448/IAS.18.7.20770. eCollection 2015. No abstract available.

2.

High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study.

Mossoro-Kpinde CD, Gody JC, Mboumba Bouassa RS, Mbitikon O, Jenabian MA, Robin L, Matta M, Zeitouni K, Longo JD, Costiniuk C, Grésenguet G, Touré Kane NC, Bélec L.

Medicine (Baltimore). 2017 Mar;96(10):e6282. doi: 10.1097/MD.0000000000006282.

3.

Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern.

Muri L, Gamell A, Ntamatungiro AJ, Glass TR, Luwanda LB, Battegay M, Furrer H, Hatz C, Tanner M, Felger I, Klimkait T, Letang E; KIULARCO Study Group.

AIDS. 2017 Jan 2;31(1):61-70.

4.

Frequent Episodes of Detectable Viremia in HIV Treatment-Experienced Children is Associated with a Decline in CD4+ T-cells Over Time.

Paintsil E, Martin R, Goldenthal A, Bhandari S, Andiman W, Ghebremichael M.

J AIDS Clin Res. 2016 Apr;7(4). pii: 565. doi: 10.4172/2155-6113.1000565. Epub 2016 Apr 14.

5.

A Case Series of Acquired Drug Resistance-Associated Mutations in Human Immunodeficiency Virus-Infected Children: An Emerging Public Health Concern in Rural Africa.

Gamell A, Muri L, Ntamatungiro A, Nyogea D, Luwanda LB, Hatz C, Battegay M, Felger I, Tanner M, Klimkait T, Letang E.

Open Forum Infect Dis. 2015 Dec 17;3(1):ofv199. doi: 10.1093/ofid/ofv199. eCollection 2016 Jan.

6.

The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children.

Vreeman RC, Scanlon ML, McHenry MS, Nyandiko WM.

J Int AIDS Soc. 2015 Dec 2;18(Suppl 6):20258. doi: 10.7448/IAS.18.7.20258. eCollection 2015.

7.

Past, present and future molecular diagnosis and characterization of human immunodeficiency virus infections.

Tang YW, Ou CY.

Emerg Microbes Infect. 2012 Aug;1(8):e19. doi: 10.1038/emi.2012.15. Epub 2012 Aug 22. Review.

8.

Pulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the Literature.

L'Huillier AG, Posfay-Barbe KM, Pictet H, Beghetti M.

Front Pediatr. 2015 Apr 7;3:25. doi: 10.3389/fped.2015.00025. eCollection 2015. Review.

9.

Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America.

Duarte HA, Harris DR, Tassiopoulos K, Leister E, Negrini SF, Ferreira FF, Cruz ML, Pinto J, Allison S, Hazra R; NISDI PLACES Study Group.

Braz J Infect Dis. 2015 May-Jun;19(3):263-71. doi: 10.1016/j.bjid.2015.01.004. Epub 2015 Mar 3.

10.

24-Month adherence, tolerance and efficacy of once-a-day antiretroviral therapy with didanosine, lamivudine, and efavirenz in African HIV-1 infected children: ANRS 12103/12167.

Hien H, Meda N, Diagbouga S, Zoure E, Yaméogo S, Tamboura H, Somé J, Ouiminga A, Rouet F, Drabo A, Hien A, Nicolas J, Chappuy H, Van de Perre P, Msellati P, Nacro B.

Afr Health Sci. 2013 Jun;13(2):287-94. doi: 10.4314/ahs.v13i2.13.

11.

Enhancing psychosocial support for HIV positive adolescents in Harare, Zimbabwe.

Mavhu W, Berwick J, Chirawu P, Makamba M, Copas A, Dirawo J, Willis N, Araya R, Abas MA, Corbett EL, Mungofa S, Laver SM, Cowan FM.

PLoS One. 2013 Jul 23;8(7):e70254. doi: 10.1371/journal.pone.0070254. Print 2013.

12.

Pooled HIV-1 RNA viral load testing for detection of antiretroviral treatment failure in Kenyan children.

Chohan BH, Tapia K, Merkel M, Kariuki AC, Khasimwa B, Olago A, Gichohi R, Obimbo EM, Wamalwa DC.

J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):e87-93. doi: 10.1097/QAI.0b013e318292f9cd.

13.

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

ARROW Trial team, Kekitiinwa A, Cook A, Nathoo K, Mugyenyi P, Nahirya-Ntege P, Bakeera-Kitaka S, Thomason M, Bwakura-Dangarembizi M, Musiime V, Munderi P, Naidoo-James B, Vhembo T, Tumusiime C, Katuramu R, Crawley J, Prendergast AJ, Musoke P, Walker AS, Gibb DM.

Lancet. 2013 Apr 20;381(9875):1391-403. doi: 10.1016/S0140-6736(12)62198-9. Epub 2013 Mar 7.

14.

High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

de Mulder M, Yebra G, Navas A, de José MI, Gurbindo MD, González-Tomé MI, Mellado MJ, Saavedra-Lozano J, Muñoz-Fernández MÁ, de Ory SJ, Ramos JT, Holguín A; Madrid Cohort of HIV-Infected Children.

PLoS One. 2012;7(12):e52155. doi: 10.1371/journal.pone.0052155. Epub 2012 Dec 17.

15.

Building adherence-competent communities: factors promoting children's adherence to anti-retroviral HIV/AIDS treatment in rural Zimbabwe.

Campbell C, Skovdal M, Mupambireyi Z, Madanhire C, Nyamukapa C, Gregson S.

Health Place. 2012 Mar;18(2):123-31. doi: 10.1016/j.healthplace.2011.07.008. Epub 2011 Sep 14.

16.

Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda.

Ahoua L, Guenther G, Rouzioux C, Pinoges L, Anguzu P, Taburet AM, Balkan S, Olson DM, Olaro C, Pujades-Rodríguez M.

BMC Pediatr. 2011 Jul 26;11:67. doi: 10.1186/1471-2431-11-67.

17.

When masculinity interferes with women's treatment of HIV infection: a qualitative study about adherence to antiretroviral therapy in Zimbabwe.

Skovdal M, Campbell C, Nyamukapa C, Gregson S.

J Int AIDS Soc. 2011 Jun 9;14:29. doi: 10.1186/1758-2652-14-29.

18.

Monitoring Antiretroviral Therapy in HIV-Infected Children in Resource-Limited Countries: A Tale of Two Epidemics.

Paintsil E.

AIDS Res Treat. 2011;2011:280901. doi: 10.1155/2011/280901. Epub 2010 Dec 2.

19.
20.

Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?

Bouazza N, Hirt D, Bardin C, Diagbouga S, Nacro B, Hien H, Zoure E, Rouet F, Ouiminga A, Blanche S, Van De Perre P, Tréluyer JM, Msellati P, Urien S.

Antimicrob Agents Chemother. 2010 Aug;54(8):3280-6. doi: 10.1128/AAC.00306-10. Epub 2010 Jun 1.

Supplemental Content

Support Center